Hanx Biopharmaceuticals Appoints Xiao Jieyu as Executive Director and CFO
I'm PortAI, I can summarize articles.
Hanx Biopharmaceuticals (Wuhan) Co. Ltd. has appointed Ms. Xiao Jieyu as Executive Director and CFO, effective February 8, 2026. The company also announced the resignation of its joint company secretary, CFO, secretary of the board, and vice general manager, alongside the appointment of a new CFO and secretary of the board.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments